Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Alzheimer's disease biomarker utilization at first referral enhances differential diagnostic precision with simultaneous exclusion of Creutzfeldt-Jakob disease.
Wang Z, Lewis V, Stehmann C, Varghese S, Senesi M, McGlade A, Ellett LJ, Doecke JD, Eratne D, Velakoulis D, Masters CL, Collins SJ, Li QX. Wang Z, et al. Among authors: doecke jd. Alzheimers Dement (Amst). 2024 Feb 13;16(1):e12548. doi: 10.1002/dad2.12548. eCollection 2024 Jan-Mar. Alzheimers Dement (Amst). 2024. PMID: 38352040 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 39112039
Deciphering ApoE Genotype-Driven Proteomic and Lipidomic Alterations in Alzheimer's Disease Across Distinct Brain Regions.
Odenkirk MT, Zheng X, Kyle JE, Stratton KG, Nicora CD, Bloodsworth KJ, Mclean CA, Masters CL, Monroe ME, Doecke JD, Smith RD, Burnum-Johnson KE, Roberts BR, Baker ES. Odenkirk MT, et al. Among authors: doecke jd. J Proteome Res. 2024 Aug 2;23(8):2970-2985. doi: 10.1021/acs.jproteome.3c00604. Epub 2024 Jan 18. J Proteome Res. 2024. PMID: 38236019 Free PMC article.
Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
Chételat G, Villemagne VL, Pike KE, Ellis KA, Bourgeat P, Jones G, O'Keefe GJ, Salvado O, Szoeke C, Martins RN, Ames D, Masters CL, Rowe CC; Australian Imaging Biomarkers and Lifestyle Study of ageing (AIBL) Research Group. Chételat G, et al. Brain. 2011 Mar;134(Pt 3):798-807. doi: 10.1093/brain/awq383. Epub 2011 Feb 9. Brain. 2011. PMID: 21310725
Blood-based protein biomarkers for diagnosis of Alzheimer disease.
Doecke JD, Laws SM, Faux NG, Wilson W, Burnham SC, Lam CP, Mondal A, Bedo J, Bush AI, Brown B, De Ruyck K, Ellis KA, Fowler C, Gupta VB, Head R, Macaulay SL, Pertile K, Rowe CC, Rembach A, Rodrigues M, Rumble R, Szoeke C, Taddei K, Taddei T, Trounson B, Ames D, Masters CL, Martins RN; Alzheimer's Disease Neuroimaging Initiative; Australian Imaging Biomarker and Lifestyle Research Group. Doecke JD, et al. Arch Neurol. 2012 Oct;69(10):1318-25. doi: 10.1001/archneurol.2012.1282. Arch Neurol. 2012. PMID: 22801742 Free PMC article.
Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's disease.
Rembach A, Doecke JD, Roberts BR, Watt AD, Faux NG, Volitakis I, Pertile KK, Rumble RL, Trounson BO, Fowler CJ, Wilson W, Ellis KA, Martins RN, Rowe CC, Villemagne VL, Ames D, Masters CL, AIBL research group, Bush AI. Rembach A, et al. Among authors: doecke jd. J Alzheimers Dis. 2013;34(1):171-82. doi: 10.3233/JAD-121474. J Alzheimers Dis. 2013. PMID: 23168449
A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study.
Burnham SC, Faux NG, Wilson W, Laws SM, Ames D, Bedo J, Bush AI, Doecke JD, Ellis KA, Head R, Jones G, Kiiveri H, Martins RN, Rembach A, Rowe CC, Salvado O, Macaulay SL, Masters CL, Villemagne VL; Alzheimer’s Disease Neuroimaging Initiative; Australian Imaging, Biomarkers and Lifestyle Study Research Group. Burnham SC, et al. Among authors: doecke jd. Mol Psychiatry. 2014 Apr;19(4):519-26. doi: 10.1038/mp.2013.40. Epub 2013 Apr 30. Mol Psychiatry. 2014. PMID: 23628985
142 results